Semin Respir Crit Care Med 2004; 25(4): 387-397
DOI: 10.1055/s-2004-832718
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Diagnosis and Treatment of Early Lung Cancer: As It Stands Today

Francis D. Sheski1 , Praveen N. Mathur1
  • 1Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
30. August 2004 (online)

Preview

Treatment of “early” stage lung cancer should offer the patient the best chance for cure. Disease-free survival after surgical resection of lung carcinoma in situ has been reported as over 90%. For “microinvasive” lung cancer it may be similar. After resection of stage IA non-small cell lung cancer, survival at 5 years is ∼60 to 70%. If endoscopic or bronchoscopic treatments of early stage lung cancer can offer similar disease-free survival with less perioperative mortality, morbidity, and cost, then they may be alternative front-line therapies. Regardless of therapeutic choice, the initial hurdle is developing a practical detection method for early stage disease. This article reviews early stage lung cancer detection by fluorescence bronchoscopy and potential treatment by the endoscopic techniques of photodynamic therapy, brachytherapy, neodymium:yttrium-aluminum-garnet (Nd:YAG) laser, electrocautery, and cryotherapy.

REFERENCES

Francis D SheskiM.D. 

Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University School of Medicine

550 North University Blvd., Ste. 5450

Indianapolis, IN 46202

eMail: FSheski@iupui.edu